Literature DB >> 23879180

Hump-nosed pit viper (Hypnale hypnale) envenoming causes mild coagulopathy with incomplete clotting factor consumption.

K Maduwage1, F E Scorgie, A Silva, S Shahmy, F Mohamed, C Abeysinghe, H Karunathilake, L F Lincz, C A Gnanathasan, G K Isbister.   

Abstract

CONTEXT: Limited information exists on the coagulopathy caused by hump-nosed pit viper (Hypnale hypnale) envenoming.
OBJECTIVES: This study aimed to characterise the coagulopathy in hump-nosed pit viper bites by measuring laboratory clotting times and factor studies.
MATERIALS AND METHODS: Cases of hump-nosed pit viper envenoming were included from a prospective cohort study of Sri Lankan snake-bite patients. Patient age, sex, snake identification, time of bite and clinical effects were recorded. Patients did not receive anti-venom because no specific anti-venom to hump-nosed vipers exists. All patients received supportive care and serial 20-min whole blood clotting tests (WBCT20). The prothrombin time (PT), international normalised ratio (INR), activated partial thromboplastin time (aPTT), coagulation factors I, II, V, VII, VIII, IX and X, von Willebrand factor (vWF) antigen and D-Dimer concentrations were measured. The median of highest or lowest test result for each patient was reported with interquartile range (IQR). Results. There were 80 hump-nosed pit viper bites, median age was 37 years (IQR: 26-51 years) and 48 were male. The WBCT20 was positive in one patient. The median highest INR was 1.9 (1.5-2.2; Range: 1.3 to > 12) and median highest aPTT was 54 s (46-72 s; Range: 35-170 s). There was low fibrinogen [median: 1.3 g/L;1, -1.8 g/L; Range: < 0.2-2.9], low factor VIII levels [median: 23%; 16-37%] and low factor V levels [median: 43%; 23-74%]. D-Dimer concentrations [median: 3.4 mg/L; 2-7.4 mg/L] were slightly elevated. Factors II, VII and X and vWF antigen concentrations were normal. DISCUSSION AND
CONCLUSIONS: Hump-nosed pit viper bites result in a mild coagulopathy which is usually not detected by a WBCT20. It is characterised by mild elevation of INR, low fibrinogen and Factors V and VIII which may be consistent with the venom containing a thrombin-like enzyme.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23879180     DOI: 10.3109/15563650.2013.811589

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  17 in total

1.  Venom Concentrations and Clotting Factor Levels in a Prospective Cohort of Russell's Viper Bites with Coagulopathy.

Authors:  Geoffrey K Isbister; Kalana Maduwage; Fiona E Scorgie; Seyed Shahmy; Fahim Mohamed; Chandana Abeysinghe; Harendra Karunathilake; Margaret A O'Leary; Christeine A Gnanathasan; Lisa F Lincz
Journal:  PLoS Negl Trop Dis       Date:  2015-08-21

2.  Population Pharmacokinetics of an Indian F(ab')2 Snake Antivenom in Patients with Russell's Viper (Daboia russelii) Bites.

Authors:  Geoffrey K Isbister; Kalana Maduwage; Ana Saiao; Nicholas A Buckley; Shaluka F Jayamanne; Shahmy Seyed; Fahim Mohamed; Umesh Chathuranga; Alexandre Mendes; Chandana Abeysinghe; Harindra Karunathilake; Indika Gawarammana; David G Lalloo; H Janaka de Silva
Journal:  PLoS Negl Trop Dis       Date:  2015-07-02

3.  Detection of venom after antivenom is not associated with persistent coagulopathy in a prospective cohort of Russell's viper (Daboia russelii) envenomings.

Authors:  Kalana Maduwage; Margaret A O'Leary; Fiona E Scorgie; Seyed Shahmy; Fahim Mohamed; Chandana Abeysinghe; Harindra Karunathilake; Lisa F Lincz; Christeine A Gnanathasan; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2014-12-18

4.  Current treatment for venom-induced consumption coagulopathy resulting from snakebite.

Authors:  Kalana Maduwage; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

5.  A randomized controlled trial of fresh frozen plasma for coagulopathy in Russell's viper (Daboia russelii) envenoming.

Authors:  G K Isbister; S Jayamanne; F Mohamed; A H Dawson; K Maduwage; I Gawarammana; D G Lalloo; H J de Silva; F E Scorgie; L F Lincz; N A Buckley
Journal:  J Thromb Haemost       Date:  2017-02-16       Impact factor: 5.824

Review 6.  Novel Treatment Strategy for Patients with Venom-Induced Consumptive Coagulopathy from a Pit Viper Bite.

Authors:  Eun Jung Park; Sangchun Choi; Hyuk-Hoon Kim; Yoon Seok Jung
Journal:  Toxins (Basel)       Date:  2020-05-05       Impact factor: 4.546

7.  Diagnosis of snake envenomation using a simple phospholipase A2 assay.

Authors:  Kalana Maduwage; Margaret A O'Leary; Geoffrey K Isbister
Journal:  Sci Rep       Date:  2014-04-29       Impact factor: 4.379

Review 8.  Hump-nosed viper bite: an important but under-recognized cause of systemic envenoming.

Authors:  Mitrakrishnan Chrishan Shivanthan; Jevon Yudhishdran; Rayno Navinan; Senaka Rajapakse
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2014-06-06

9.  Enzyme immunoassays for detection and quantification of venoms of Sri Lankan snakes: Application in the clinical setting.

Authors:  Kalana Prasad Maduwage; Indika Bandara Gawarammana; José María Gutiérrez; Chaminda Kottege; Rohana Dayaratne; Nuwan Prasada Premawardena; Sujeewa Jayasingha
Journal:  PLoS Negl Trop Dis       Date:  2020-10-05

Review 10.  Bedside Coagulation Tests in Diagnosing Venom-Induced Consumption Coagulopathy in Snakebite.

Authors:  Supun Wedasingha; Geoffrey Isbister; Anjana Silva
Journal:  Toxins (Basel)       Date:  2020-09-10       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.